Latest News & Features
article
As digital technologies and artificial intelligence continue to revolutionise the healthcare industry, key stakeholders are looking to understand the legal environment to ensure quick market uptake. 29 July 2021
Big Pharma
In May, a consortium of pharmaceutical companies came together to pitch a new plan to help provide more equitable access to COVID-19 vaccines. 29 July 2021
Biotechnology
Bio-Rad Laboratories has settled its long-running dispute with 10X Genomics over patents covering genetic analysis tech and both companies have negotiated an agreement to cross-license their products. 29 July 2021
Americas
The US Food and Drug Administration has approved the first-ever interchangeable biosimilar product, an insulin treatment for Types 1 and 2 diabetes. 29 July 2021
Plant Varieties
A New York federal court has denied biotechnology company Amyris’ bid for arbitration in an $881 million trade secrets and patent infringement dispute with cannabis firm Lavvan. 27 July 2021
Americas
Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump. 27 July 2021
Biotechnology
A California jury has ordered Novartis to pay $178 million to rival drugmaker Daiichi Sankyo for willfully infringing two cancer drug patents. 26 July 2021
Generics
The Delhi High Court has cleared the way for a slew of generic diabetes drugs to arrive on the Indian market after it rejected AstraZeneca’s request for a blocking order. 22 July 2021
Americas
The US Patent Trial and Appeal Board has given the go-ahead for an inter partes review of a Chinese pharma company’s US patent related to a treatment for Alzheimer’s. 22 July 2021
Generics
In the second of a four-part series, Sophie Topham of Marks & Clerk explains the rules around the exemption for studies, tests, and trials required for generic and biosimilar medicines. 22 July 2021